NL-OMON31937尚未招募4 期
Open label extension of the LOCKCYST trial;LOCKCYST: Long-acting lanreotide as a volume reducing treatment of polycystic livers - LOCKCYST trial extension
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •18 yrs-of age
- •Multiple livercysts > 20 in PCLD- or ADPKD-patients
- •Cooperating patient
- •Is willing and able to comply with the study drug regimen and all other study requirements.
- •Willingness to give written informed consent
排除标准
- •Use of oral anticonceptives or estrogen suppletion
- •Females who are pregnant or breast-feeding
- •History or other evidence of chronic pulmonary disease associated with functional limitation
- •History of severe cardiac disease (eg, NYHA Functional Class III or IV, myocardial infarction within 6 months, ventricular tachyarrhythmias requiring ongoing treatment, unstable angina or other significant cardiovascular diseases). In addition, patients with documented or presumed coronary artery disease or cerebrovascular disease should not be enrolled.
- •History or other evidence of severe illness or any other conditions which would make the patient, in the opinion of the investigator, unsuitable for the study
- •Symptomatic gallstones (lanreotide decreases gall bladder volume)
- •Renal failure requiring hemodialysis
研究者
相似试验
进行中（未招募）
1 期
An open label extension study for long-term safety of GWP42003-P in patients with Rett SyndromeEUCTR2019-001605-24-ITGW RESEARCH LTD.252
进行中（未招募）
1 期
An open label extension study for long-term safety of GWP42003-P in patients with Rett SyndromeRett syndrome (RTT) [typical or atypical]MedDRA version: 20.0Level: PTClassification code 10077709Term: Rett syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2019-001605-24-GBGW Research Ltd252
进行中（未招募）
1 期
An open label extension study for long-term safety of GWP42003-P in patients with Rett SyndromeRett syndrome (RTT) [typical or atypical]MedDRA version: 20.0Level: PTClassification code 10077709Term: Rett syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2019-001605-24-ESGW Research Ltd21
进行中（未招募）
1 期
An open-label extension trial to investigate the safety and tolerability of long-term treatment with transdermal rotigotine in subjects with idiopathic restless legs syndromeRestless Leg's SyndromeMedDRA version: 7.0Level: LLTClassification code 10058920EUCTR2005-002611-25-ESSchwarz Biosciences GmbH510
进行中（未招募）
不适用
An open-label extension trial to investigate the safety and tolerability of long-term treatment with transdermal rotigotine in subjects with idiopathic restless legs syndromeRestless Leg's SyndromeMedDRA version: 7.0Level: LLTClassification code 10058920EUCTR2005-002611-25-ATSchwarz Biosciences GmbH420